China Salt Chemical(600328)

Search documents
中盐化工(600328) - 中盐化工关于参加内蒙古辖区上市公司2023年投资者网上集体接待日活动的公告
2023-06-05 07:35
证券代码:600328 证券简称:中盐化工 公告编号:(临)2023-031 中盐内蒙古化工股份有限公司关于参加内蒙古辖区 上市公司 2023 年投资者网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与投资者的互动交流,中盐内蒙古化工股份有限公司 (以下简称"公司")将参加由内蒙古证监局、内蒙古上市公司协会与深 圳市全景网络有限公司联合举办的"2023 年内蒙古辖区上市公司投资者 集体接待日活动",现将相关事项公告如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网 站(https://rs.p5w.net),或关注微信公众号:全景财经,或下载全景 路演 APP,参与本次互动交流,活动时间为 2023 年 6 月 9 日(星期五) 15:30-17:00。届时公司高管将在线就公司 2022 年度业绩、公司治理、发 展战略、经营状况、融资计划、股权激励和可持续发展等投资者关心的问 题,与投资者进行沟通与交流,欢迎广大投资者踊跃参与! 特此公告。 中盐内蒙古化工股份有限公 ...
中盐化工:中盐内蒙古化工股份有限公司关于召开2022年度暨2023年第一季度业绩暨现金分红说明会的公告
2023-05-16 10:13
证券代码:600328 证券简称:中盐化工 公告编号:2023-027 中盐内蒙古化工股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩 暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 中盐内蒙古化工股份有限公司(以下简称"公司")已于 2023 年 4 月 28 日发布公司 2022 年度报告及 2023 年一季度报告,为便于 广大投资者更全面深入地了解公司2022 年度及2023 年一季度经营成 果、财务状况,公司计划于 2023 年 05 月 24 日上午 10:00-11:30 举 行 2022 年度暨 2023 年第一季度业绩暨现金分红说明会,就投资者关 心的问题进行交流。 会议召开时间:2023 年 05 月 24 日(星期三)上午 10:00-11:30 会议召开地点:上海证券交易所上证路演中心(网址: http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心视频录播和网络互动 投资者可于 2023 年 05 月 17 日 ...
中盐化工(600328) - 2023 Q1 - 季度财报
2023-04-27 16:00
Financial Performance - The company's operating revenue for Q1 2023 was CNY 4,723,402,742.81, representing a year-on-year increase of 1.70%[5] - Net profit attributable to shareholders decreased by 16.28% year-on-year, primarily due to weak downstream market demand and significant price declines for PVC and resin[8] - Basic earnings per share were CNY 0.4478, reflecting a decrease of 29.22%[5] - Net profit for Q1 2023 was approximately $679.86 million, compared to $721.04 million in Q1 2022, reflecting a decrease of about 5.7%[38] - Total comprehensive income for the first quarter of 2023 was approximately CNY 679.86 million, a decrease from CNY 721.04 million in the same period of 2022, representing a decline of about 5.7%[40] - Net income attributable to the parent company for Q1 2023 was CNY 507.21 million, down from CNY 605.84 million in Q1 2022, reflecting a decrease of approximately 16.3%[40] Cash Flow and Liquidity - The net cash flow from operating activities was CNY 234,561,866.79, down 75.51% compared to the previous year[5] - Cash flow from operating activities for Q1 2023 was CNY 234.56 million, significantly lower than CNY 957.67 million in Q1 2022, a decrease of approximately 75.5%[43] - Cash and cash equivalents decreased to RMB 2,034,848,201.15 from RMB 2,624,885,298.64, reflecting a decline of about 22.5%[26] - Cash inflow from operating activities was ¥1.17 billion, down from ¥1.81 billion in Q1 2022, a decline of 35.4%[53] - The net cash flow from operating activities was -$418.03 million, a significant decrease compared to $583.85 million in the previous period[55] Assets and Liabilities - Total assets decreased by 5.65% to CNY 19,871,367,555.94 compared to the end of the previous year[8] - The total assets decreased from approximately $21.06 billion in the previous period to about $19.87 billion, a decline of approximately 5.63%[29] - Total liabilities decreased from approximately $8.67 billion to about $6.95 billion, a reduction of approximately 19.9%[29] - The company's total current assets of RMB 6,268,710,462.71 as of March 31, 2023, down from RMB 7,245,612,359.99 as of December 31, 2022, representing a decrease of approximately 13.5%[26] - The total liabilities decreased from ¥4.23 billion to ¥3.79 billion, reflecting a reduction of approximately 10.4%[51] Research and Development - The company's R&D expenses increased by 57.54% during the reporting period, indicating a continued commitment to innovation[12] - Research and development expenses increased to approximately $32.81 million in Q1 2023 from $20.83 million in Q1 2022, an increase of about 57.5%[38] - Research and development expenses for Q1 2023 were ¥94.34 million, indicating ongoing investment in innovation[51] Operational Changes and Mergers - The company has completed the merger of its wholly-owned subsidiary, Zhongyan Jilantai Chlor-Alkali Chemical Co., Ltd., with Zhongyan Jilantai Polymer Materials Co., Ltd., enhancing operational efficiency[22] - The company plans to acquire 100% equity of Anhui Tianchen Chemical Co., Ltd. through capital increase and share expansion, aiming to strengthen its market position in the resin industry[23] - The company’s subsidiary, Zhongyan Huadong Chemical Co., Ltd., has faced operational challenges leading to continuous losses, resulting in its dissolution[22] Inventory Management - The company reported a significant reduction in inventory from RMB 1,318,830,022.71 to RMB 869,906,945.66, indicating improved inventory management[26] - The company’s inventory decreased to CNY 170.36 million in Q1 2023 from CNY 224.76 million in Q1 2022, representing a reduction of about 24.2%[45] Shareholder Information - The company’s controlling shareholder, Zhongyan Jilantai Salt Chemical Group Co., Ltd., holds 45.48% of the shares, establishing a significant influence over the company[21] - The company’s total equity attributable to shareholders increased by 2.10% to CNY 11,719,237,946.75 compared to the end of the previous year[8] - The total equity attributable to shareholders increased to approximately $11.72 billion from $11.48 billion, an increase of about 2.1%[29] - The total equity increased to ¥7.25 billion from ¥7.01 billion, reflecting a growth of approximately 3.4%[51]
中盐化工(600328) - 2022 Q4 - 年度财报
2023-04-27 16:00
Environmental Performance - The company achieved a daily average emission concentration of 11.2 mg/Nm³ for sulfur dioxide, 35.7 mg/Nm³ for nitrogen oxides, and 2.4 mg/Nm³ for particulate matter, meeting the ultra-low emission standards[5] - The sodium industry company produced 430.9 tons of chromium-containing waste salt mud in 2022, with no exceedance of standards[6] - The thermal power workshop of the sodium industry company had a permitted emission of 63.91 tons/year for sulfur dioxide, 130.81 tons/year for nitrogen oxides, and 40.57 tons/year for particulate matter, with no exceedance of standards[7] - The chlorine-alkali company reported a permitted emission of 4,513.3 tons/year for sulfur dioxide, 1,468.88 tons/year for nitrogen oxides, and 1,320.4 tons/year for particulate matter, with daily average emissions of 19.38 mg/Nm³ for sulfur dioxide, 37.09 mg/Nm³ for nitrogen oxides, and 1.71 mg/Nm³ for particulate matter in 2022[10] - The company invested 21,256.41 million yuan in environmental protection during the reporting period[22] Financial Performance - The company achieved a net profit of 2,378,297,903.23 yuan in 2022, with a net profit attributable to shareholders of 1,863,927,317.64 yuan, resulting in earnings per share of 1.907 yuan[25] - The proposed cash dividend for 2022 is 4.94 yuan per 10 shares, totaling 559,592,146.75 yuan, representing a cash dividend payout ratio of 30.02%[25] - The company achieved operating revenue of CNY 18.16 billion in 2022, an increase of 35.41% compared to the previous year[77] - The net profit attributable to shareholders reached CNY 1.86 billion, up 26.20% year-on-year[77] - The net cash flow from operating activities was CNY 1.72 billion, a decrease of 46.51% compared to the previous year[77] - Total assets at the end of 2022 amounted to CNY 19.91 billion, reflecting a 17.80% increase from the end of 2021[77] Corporate Governance - The company maintained effective internal control over financial reporting as per the audit opinion issued by the accounting firm[11] - The company established a governance special working group to address 119 issues related to corporate governance from December 2020 to December 2022[12] - The company has established a governance structure with clear responsibilities and decision-making processes, enhancing operational efficiency and protecting investor rights[20] - The company has a total of 8 board members, which is below the required 9, and plans to complete the nomination and election of board candidates promptly[16] - The company has implemented a revised management contract system for its executive team, enhancing performance evaluation and incentive mechanisms[38] - The company has a commitment to enhancing the role of independent directors in decision-making processes, improving decision quality and risk prevention[42] Investor Relations - The company received over 100 investor visits and meetings in 2022, actively engaging with investors through various communication channels[19] - The company organized over 50 investor roadshows following the approval of its non-public offering by the CSRC, facilitating direct communication with investors[19] - The company emphasizes the importance of investor relations management and has taken steps to improve communication and training for its board and management personnel[17] - The company has maintained its corporate website and contact information for investor relations, ensuring transparency and accessibility[32] Research and Development - The company established a PVC key laboratory and a polymer materials engineering R&D center to enhance technological content and extend the industrial chain[91] - During the reporting period, the company received 40 patent applications and 38 authorized patents, along with special funding of 5 million yuan from Alashan League[91] - Research and development expenses rose by 52.44% year-on-year, driven by increased investment in quality improvement, energy conservation, and emissions reduction initiatives[114] - Total R&D investment accounted for 2.45% of operating revenue, with no capitalized R&D expenditures reported[148] Production and Sales - The company produced 416.5 thousand tons of soda ash, completing 109.03% of its annual production plan[87] - The sales volume of soda ash reached 436.41 thousand tons, achieving 112.82% of the annual sales target[87] - The production of polyvinyl chloride (PVC) was 419.8 thousand tons, fulfilling 104.95% of the annual plan[87] - The company produced 7.146 million bottles, achieving 101.58% of the annual plan, and sold 7.2492 million bottles, completing 96.66% of the annual plan[88] - The production of Cistanche Deserticola Granules was 2.3216 million boxes, reaching 55.94% of the annual plan, while sales were 2.8005 million boxes, completing 70.01% of the annual plan[88] Strategic Goals - The company aims to build a world-class chemical enterprise through continuous innovation and operational excellence[86] - The company plans to enhance operational efficiency through water and energy conservation, aiming to become a high-tech enterprise with significant technological advancements[122] - The company aims to optimize its business model and enhance its competitive edge by focusing on technological innovation and industry chain integration[124] - The company plans to focus on expanding market channels in grassroots health institutions and outpatient channels for the Cistanche deserticola kidney granules due to challenges in hospital development[199]
中盐化工(600328) - 2022 Q3 - 季度财报
2022-10-28 16:00
2022 年第三季度报告 单位:元 币种:人民币 1 / 25 证券代码:600328 证券简称:中盐化工 中盐内蒙古化工股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 本报告期 年初至报告期 | --- | --- | --- | --- | --- | |------------------------------------------------|------------------|------------------------------|-------------------|------------------- ...
中盐化工(600328) - 2022 Q2 - 季度财报
2022-08-18 16:00
2022 年半年度报告 公司代码:600328 公司简称:中盐化工 中盐内蒙古化工股份有限公司 2022 年半年度报告 1 / 214 2022 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人周杰、主管会计工作负责人陈云泉及会计机构负责人(会计主管人员)宋大勇声 明:保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 报告期,公司不进行利润分配及资本公积转增股本。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中涉及的未来计划、发展战略等前瞻性陈述,不构成公司对投资者的实质承诺,敬请 投资者注意投资风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况? 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 公 ...
中盐化工(600328) - 2021 Q4 - 年度财报
2022-04-21 16:00
Financial Performance - The company reported a net profit of RMB 1,742,284,515.23 for the year 2021, with a net profit attributable to shareholders of RMB 1,476,906,871.09, resulting in earnings per share of RMB 1.542[4]. - The total distributable profit at the end of the year was RMB 2,624,071,991.64, with a proposed cash dividend of RMB 4.7 per 10 shares, totaling RMB 450,102,358.24, representing a cash dividend payout ratio of 30.48%[4]. - The company's operating revenue for 2021 was approximately ¥13.41 billion, a 37.54% increase compared to ¥9.75 billion in 2020[20]. - Net profit attributable to shareholders for 2021 reached approximately ¥1.48 billion, reflecting a significant growth of 166.61% from ¥553.96 million in 2020[20]. - The net cash flow from operating activities for 2021 was approximately ¥3.22 billion, a 95.42% increase from ¥1.65 billion in 2020[23]. - The total assets at the end of 2021 amounted to approximately ¥16.90 billion, representing a 26.26% increase from ¥13.39 billion at the end of 2020[23]. - Basic earnings per share for 2021 were ¥1.5422, up 155.33% from ¥0.604 in 2020[23]. - The weighted average return on equity for 2021 was 20.82%, an increase of 11.77 percentage points compared to 9.05% in 2020[23]. Risk Management - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[6]. - There are no significant risks related to the provision of guarantees outside the prescribed decision-making procedures[6]. - The company has outlined potential risks in its future development discussions, which are detailed in the report[6]. - The company emphasizes the importance of investor awareness regarding the risks associated with forward-looking statements in the report[6]. - The company has established a comprehensive compliance risk management system, ensuring no major risk events occurred during the year[41]. Operational Efficiency - The company achieved significant technological innovation, with a total of 215 authorized patents, including 1 invention patent and 11 utility model patents in the year[41]. - The company’s overall efficiency improved due to optimized production organization and capacity release[35]. - The company is focusing on optimizing production processes and enhancing automation to address production stability challenges[49]. - The company is actively addressing energy consumption issues, implementing a special plan for energy conservation and carbon reduction[47]. Market Position and Strategy - The company holds a leading position in the global sodium metal market with a production capacity of 65,000 tons, accounting for 36.4% of global capacity, and produced 817.118 tons in 2021[56]. - The company is the largest producer of soda ash in China with a production capacity of 3.8 million tons, serving various industries such as glass and pharmaceuticals[57]. - The company plans to enhance its market presence by expanding its operations across multiple provinces, aiming to establish itself as a leading circular economy salt chemical base in Western China[62]. - The company is committed to improving employee capabilities through a refined incentive mechanism and optimizing human resource allocation[53]. Research and Development - The company’s research and development expenses increased by 138.71% year-on-year, amounting to approximately CNY 291.92 million, indicating a strong focus on innovation[68]. - The total R&D expenditure amounted to 291,920,890.91 CNY, representing 2.18% of total operating income, with a significant increase of 138.71% compared to the previous year[90]. - The company reported a significant increase of 817.51% in R&D investment for the "Compound Licorice Tablets" project, totaling CNY 569.59 million[132]. - The company has 533 R&D personnel, accounting for 6.1% of the total workforce, indicating a strong commitment to innovation and technology development[91]. Acquisitions and Investments - The company completed the acquisition of 100% equity in Qinghai Faitou Soda Industry, enhancing its market position[36]. - The company completed non-public stock issuance plans to raise up to 2.8 billion yuan for acquiring 100% equity of Faitou Chemical[46]. - The company completed the acquisition of 100% equity in the Faitou Chemical Industry for a base price of 283,000 million RMB, finalizing the transaction on September 3, 2021[177]. Production and Sales - PVC production reached 420,000 tons, completing 102.45% of the annual plan, with sales of 422,000 tons, achieving 102.93% of the plan[35]. - Soda ash production was 3.1129 million tons, completing 126.43% of the annual plan, with sales of 2.8266 million tons, achieving 114.80% of the plan[35]. - The company produced 557.43 million bottles of compound licorice tablets, completing 79.63% of the annual plan, with sales of 778.67 million bottles, achieving 111.24% of the plan[35]. Financial Management - The financial expenses decreased by 28.13% year-on-year, amounting to approximately CNY 153.39 million, due to increased operational cash flow allowing for debt repayment[69]. - The company reported a significant increase in investment cash outflow by 20,641.52% year-on-year, primarily due to payments related to the acquisition of the alkali business[71]. - The financing cash outflow decreased by 67.29% year-on-year, mainly due to reduced loan repayments compared to the previous year[71]. Compliance and Governance - The company is committed to ensuring the authenticity, accuracy, and completeness of the annual report, with all board members present at the meeting[4]. - The audit report for 2021 was issued by Tianzhi International Accounting Firm, confirming a standard unqualified opinion[4]. - The company achieved a 100% review rate for major decisions, basic systems, and economic contracts, enhancing its legal compliance capabilities[41]. Industry Trends - The domestic industrial salt market is experiencing tight supply and rising prices due to reduced production and increased costs, impacting the company's operational pressures[54]. - The pharmaceutical industry in China is experiencing good development, supported by government initiatives and increasing market demand driven by an aging population and improved consumer spending[200].
中盐化工(600328) - 2022 Q1 - 季度财报
2022-04-21 16:00
Financial Performance - The company's operating revenue for Q1 2022 reached ¥4,412,308,306.21, representing an increase of 86.57% year-on-year[4] - Net profit attributable to shareholders was ¥615,987,261.45, marking a year-on-year increase of 141.48%[4] - Basic earnings per share were ¥0.6432, which is an increase of 141.45% year-on-year[4] - Operating profit for Q1 2022 was ¥907,439,602.57, compared to ¥340,580,774.49 in Q1 2021, indicating a growth of 166.5%[37] - The net profit for the first quarter of 2022 was approximately ¥720.88 million, a significant increase of 161.5% compared to ¥275.12 million in the same period of 2021[38] - The total comprehensive income for the first quarter was ¥720.88 million, which includes a net profit attributable to shareholders of the parent company of ¥615.99 million[38] Cash Flow - The net cash flow from operating activities was ¥1,038,514,813.28, reflecting a growth of 43.08% compared to the same period last year[4] - The net cash flow from operating activities was ¥583,852,721.95, a significant increase from ¥273,894,775.40 in Q1 2021, representing a growth of approximately 113%[57] - Total cash inflow from operating activities reached ¥1,808,263,363.80, compared to ¥1,143,932,839.63 in the same period last year, indicating a year-over-year increase of about 58%[57] - The cash outflow from operating activities was ¥1,224,410,641.85, up from ¥870,038,064.23 in Q1 2021, reflecting a rise of approximately 41%[57] - The company reported a net cash outflow from investing activities of approximately ¥10.09 million, compared to a net outflow of ¥11.04 million in the first quarter of 2021[45] - The net cash flow from investment activities was ¥16,853,068.29, a turnaround from a negative cash flow of ¥8,130,839.52 in Q1 2021[57] - The net cash flow from financing activities was negative at ¥199,700,375.70, compared to a much smaller negative cash flow of ¥44,375.00 in Q1 2021[59] Assets and Liabilities - Total assets at the end of Q1 2022 amounted to ¥17,557,536,917.52, up 3.86% from the end of the previous year[7] - Current liabilities increased to ¥7,437,242,198.18 in Q1 2022 from ¥7,127,509,281.93 in Q1 2021, reflecting a rise of 4.3%[33] - The total liabilities rose to ¥4,022,483,240.02 in Q1 2022, compared to ¥3,573,802,002.45 in Q1 2021, marking an increase of about 12.5%[50] - The company's total revenue for Q1 2022 was ¥922,443,200.23, a significant increase from ¥297,041,547.78 in Q1 2021, representing a growth of approximately 210%[50] Shareholder Information - The total number of common shareholders at the end of the reporting period was 72,010[15] - The largest shareholder, China Salt Jilantai Salt Chemical Group Co., Ltd., holds 516,982,128 shares, accounting for 53.98% of the total shares[15] - The equity attributable to shareholders increased by 7.23% to ¥8,290,952,209.91 compared to the end of the previous year[7] Research and Development - Research and development expenses surged by 686.45% in the current period, indicating increased investment in innovation[14] - Research and development expenses for Q1 2022 were ¥13,597,897.22, significantly higher than ¥1,729,032.37 in Q1 2021, marking an increase of 688.5%[37] - Research and development expenses were not explicitly reported, but the company indicated a focus on innovation and product development in future strategies[54] Inventory and Accounts Receivable - The company has a total of 1,184,100,521.19 in inventory as of March 31, 2022, down from 1,486,376,736.84 at the end of 2021[27] - Accounts receivable decreased to ¥164.38 million from ¥199.65 million year-over-year[27] - The accounts receivable rose to ¥68.82 million, compared to ¥44.61 million in the previous year, reflecting a growth of 54.2%[45] Future Plans - The company has ongoing projects, including a contract to supply 1,667 tons of liquid sodium to China Nuclear Power, with a delivery deadline of November 2024[26] - The company is progressing with a non-public stock issuance plan approved by the board, with regulatory compliance ongoing[23] - The company plans to expand its market presence and explore potential mergers and acquisitions as part of its growth strategy moving forward[54]
中盐化工(600328) - 2021 Q3 - 季度财报
2021-10-26 16:00
Financial Performance - The company's operating revenue for Q3 2021 reached ¥3,399,438,180.53, representing a year-on-year increase of 38.84%[5] - Net profit attributable to shareholders was ¥436,408,040.03, a significant increase of 164.58% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥435,549,125.32, reflecting a year-on-year growth of 171.23%[5] - The basic earnings per share for the quarter was ¥0.4557, up 207.08% year-on-year[9] - Total operating revenue for the first three quarters of 2021 reached ¥9,121,332,823.29, a significant increase from ¥6,331,379,051.19 in the same period of 2020, representing an increase of approximately 44.5%[46] - Net profit for the third quarter of 2021 was ¥1,399,463,475.39, compared to ¥314,035,186.81 in the third quarter of 2020, marking an increase of about 345.5%[46] - Operating profit for the third quarter of 2021 was ¥1,695,112,129.73, up from ¥372,856,715.98 in the previous year, indicating a growth of approximately 354.5%[46] - The company reported a total comprehensive income of ¥1,399,463,475.39 for the third quarter of 2021, compared to ¥314,035,186.81 in the previous year, marking an increase of about 345.5%[48] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥17,204,153,945.09, an increase of 28.50% from the end of the previous year[9] - As of September 30, 2021, the company's total assets reached approximately 17.20 billion RMB, an increase from 13.39 billion RMB at the end of 2020, reflecting a growth of about 28%[40] - The company reported a total asset value of ¥13,388,895,102.71 as of the end of the reporting period, slightly down from ¥13,457,276,550.78 at the end of the previous year[56] - Total liabilities increased to ¥9,203,777,775.30 in 2021 from ¥6,422,390,430.77 in 2020, representing a rise of approximately 43.8%[46] - The total liabilities amounted to ¥10,629,839,830.77, reflecting a decrease from ¥10,698,221,278.84 in the previous year[56] - The company’s total liabilities amounted to approximately CNY 6.42 billion, with current liabilities at CNY 5.63 billion and non-current liabilities at CNY 787.66 million[59] Cash Flow - Cash flow from operating activities for the year-to-date was ¥3,063,702,203.36, showing a substantial increase of 187.82% year-on-year[5] - The cash inflow from operating activities for the first three quarters of 2021 reached ¥7,174,020,243.01, a significant increase of 68.5% compared to ¥4,266,576,647.84 in the same period of 2020[52] - The net cash flow from operating activities amounted to ¥3,063,702,203.36, up from ¥1,064,445,499.53 in the previous year, representing a growth of 187.5%[52] - The total cash outflow from investing activities was ¥2,671,014,608.75, compared to ¥707,944,901.81 in the same period last year, indicating a substantial increase in investment expenditures[54] - The net cash flow from investing activities was negative at -¥2,655,098,182.40, worsening from -¥362,146,547.90 in the previous year[54] - Cash inflow from financing activities totaled ¥2,451,950,000.00, a decrease from ¥3,337,732,661.47 in the same period last year[54] - The net cash flow from financing activities was -¥39,278,803.71, compared to -¥646,444,016.70 in the previous year, showing an improvement in cash management[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,969[18] - The largest shareholder, China Salt Jilantai Salt Chemical Group Co., Ltd., holds 55.14% of the shares[18] - The company’s equity structure is being optimized through the planned share reduction by its major shareholder, which will not exceed 1% of the total share capital[32] - The total equity attributable to shareholders reached CNY 6.50 billion, while total equity was CNY 6.97 billion[61] Research and Development - R&D expenses amounted to 2,024.95 million, reflecting increased investment in research and development and team building[16] - The company plans to enhance its R&D capabilities and accelerate innovation in existing products and technologies[16] - Research and development expenses for the third quarter of 2021 totaled ¥164,488,368.18, a substantial increase from ¥7,740,810.78 in the same quarter of 2020, reflecting a growth of around 2015.5%[46] Acquisitions and Investments - The acquisition of the new business contributed positively to the overall financial performance, with significant impacts on various financial metrics[15] - The company completed the acquisition of 100% equity in Hai Investment Alkali Industry for a base price of 2,830 million[28] - The company plans to raise up to 2.8 billion RMB through a non-public offering to acquire 100% equity of a subsidiary, pending approval from the China Securities Regulatory Commission[31] - Investment income was 130.87 million, primarily due to gains from the disposal of Lan Tai Coal Industry[16] Impairment Losses - Asset impairment losses totaled 268.78 million, mainly from the provision for ineffective assets[16] - Credit impairment losses reached 559.89 million, attributed to an increase in receivables[16]